BIOMAT Database Logo BIOMAT Database Logo

1,2,3-Triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: a new class of A2A adenosine receptor antagonists. 1996

P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Dipartimento di Scienze Farmaceutiche, Università degli Studi di Ferrara, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058915 Purinergic P1 Receptor Antagonists Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. Adenosine Receptor Antagonist,P1 Purinoceptor Antagonist,Purinergic P1 Receptor Antagonist,Adenosine Receptor Antagonists,P1 Purinoceptor Antagonists,Antagonist, Adenosine Receptor,Antagonist, P1 Purinoceptor,Antagonists, Adenosine Receptor,Antagonists, P1 Purinoceptor,Purinoceptor Antagonist, P1,Purinoceptor Antagonists, P1,Receptor Antagonist, Adenosine,Receptor Antagonists, Adenosine

Related Publications

P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists.
October 2010, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
February 2009, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Synthesis of novel pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: potent and selective adenosine A3 receptor antagonists.
October 2013, Archiv der Pharmazie,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
November 2005, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
March 2007, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists.
April 2010, Bioorganic & medicinal chemistry,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
August 2004, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
March 2005, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
January 2012, Bioorganic & medicinal chemistry,
P G Baraldi, and B Cacciari, and G Spalluto, and M J Pineda de las Infants, and C Zocchi, and S Ferrara, and S Dionisotti, and S FerraDDionisotti
QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype.
January 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!